Researchers have discovered a virus that could enter human cells in a similar way to COVID-19. But they caution it's much more poorly adapted to humans.

Lab experiments showed that the virus could infect human cells with high ACE2 levels, including models of human intestines ...

Tasmanians are expected to be able to access a Moderna Covid vaccine manufactured in Australia later this year.

Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.

Persistent levels of spike protein from COVID-19 vaccines could be associated with a range of chronic symptoms like excessive ...

We’re in the heart of flu season, and it’s important to be mindful of how we choose to stay healthy. The CDC recommends ...

Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday. Shares of Moderna ...

The S&P 500 plunged by 1.7% on Friday, Feb. 21, as weak economic data and earnings forecasts sent the benchmark index lower for the second straight session.

Still, Mafi says there aren't strong data on how Paxlovid affects the disease course in people who are vaccinated. His findings suggest that the benefits are about four times smaller than those ...

Researchers at the Wuhan Institute of Virology in China said they discovered a new coronavirus in bats that enters cells using the same gateway as the virus that causes Covid-19.